Cargando…

Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence

Pro-inflammatory CD4(+)CD28(−) T cells are characteristic of immunosenescence, but also of several autoimmune/inflammatory diseases. Vasoactive intestinal peptide (VIP) acts as an anti-inflammatory and immunomodulatory mediator on these cells. Our objective was to study the mutual influence between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villanueva-Romero, Raúl, Lamana, Amalia, Flores-Santamaría, Marissa, Carrión, Mar, Pérez-García, Selene, Triguero-Martínez, Ana, Tomero, Eva, Criado, Gabriel, Pablos, José L., González-Álvaro, Isidoro, Martínez, Carmen, Juarranz, Yasmina, Gomariz, Rosa P., Gutiérrez-Cañas, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761848/ https://www.ncbi.nlm.nih.gov/pubmed/33291545 http://dx.doi.org/10.3390/cells9122592

Ejemplares similares

An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance
por: Gomariz, Rosa P., et al.
Publicado: (2019)

VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures
por: Lamana, Amalia, et al.
Publicado: (2022)

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity
por: Seoane, Iria V., et al.
Publicado: (2016)

A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases
por: Martínez, Carmen, et al.
Publicado: (2019)

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis
por: Castro-Vazquez, David, et al.
Publicado: (2021)

Human CD4(+)CD45RA(+) T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide
por: Villanueva-Romero, Raúl, et al.
Publicado: (2022)

VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts
por: Pérez‐García, Selene, et al.
Publicado: (2016)

Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin
por: Pérez-García, Selene, et al.
Publicado: (2019)

The Anti-Inflammatory Mediator, Vasoactive Intestinal Peptide, Modulates the Differentiation and Function of Th Subsets in Rheumatoid Arthritis
por: Villanueva-Romero, Raúl, et al.
Publicado: (2018)

Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity
por: Seoane, Iria V., et al.
Publicado: (2015)

Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis
por: Pérez-García, Selene, et al.
Publicado: (2021)

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis
por: Martínez, Carmen, et al.
Publicado: (2014)

The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP
por: Jimeno, Rebeca, et al.
Publicado: (2014)

Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis
por: Seoane, Iria V., et al.
Publicado: (2018)

Wnt and RUNX2 mediate cartilage breakdown by osteoarthritis synovial fibroblast‐derived ADAMTS‐7 and ‐12
por: Pérez‐García, Selene, et al.
Publicado: (2019)

Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients
por: Villanueva-Romero, R., et al.
Publicado: (2019)

Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
por: Juarranz, Yasmina, et al.
Publicado: (2005)

Role of VPAC1 and VPAC2 receptors in the etiology of pregnancy rhinitis: an experimental study in rats
por: Ulkumen, Burak, et al.
Publicado: (2020)

Inhibitory Role of Growth Hormone in the Induction and Progression Phases of Collagen-Induced Arthritis
por: Villares, Ricardo, et al.
Publicado: (2018)

Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2020)

Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis
por: Triguero-Martínez, Ana, et al.
Publicado: (2022)

Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity
por: Lamana, Amalia, et al.
Publicado: (2020)

Seasonal changes in the expression of PACAP, VPAC1, VPAC2, PAC1 and testicular activity in the testis of the muskrat (Ondatra zibethicus)
por: Tang, Zeqi, et al.
Publicado: (2022)

PAC(1), VPAC(1), and VPAC(2) Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies
por: Tasma, Zoe, et al.
Publicado: (2022)

Understanding VPAC receptor family peptide binding and selectivity
por: Piper, Sarah J., et al.
Publicado: (2022)

Expression of VPAC1 in a murine model of allergic asthma
por: Lauenstein, Hans D, et al.
Publicado: (2013)

Diagnosis of Oral Cancers by Targeting VPAC Receptors: Preliminary Report
por: Nerli, Rajendra, et al.
Publicado: (2023)

VPAC: Variational projection for accurate clustering of single-cell transcriptomic data
por: Chen, Shengquan, et al.
Publicado: (2019)

The Adipokine Network in Rheumatic Joint Diseases
por: Carrión, Mar, et al.
Publicado: (2019)

Molecular and Cellular Basis of Autoimmune Diseases
por: Juarranz, Yasmina
Publicado: (2021)

Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function
por: Peyrassol, Xavier, et al.
Publicado: (2018)

The VPAC1 receptor: structure and function of a class B GPCR prototype
por: Couvineau, A., et al.
Publicado: (2012)

Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies
por: Langer, Ingrid
Publicado: (2012)

VPAC Receptor Subtypes Tune Purinergic Neuron-to-Glia Communication in the Murine Submucosal Plexus
por: Fung, Candice, et al.
Publicado: (2017)

Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors
por: Nerli, Rajendra B., et al.
Publicado: (2021)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism
por: Municio, Cristina, et al.
Publicado: (2018)

VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model
por: Storka, Angela, et al.
Publicado: (2013)

VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice
por: Ivic, Ivan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_otnuj34p84c3tmh368t2usndbj